Vanderbilt Hypertension and Blood Pressure Regulation Program
范德比尔特高血压和血压调节计划
基本信息
- 批准号:10597621
- 负责人:
- 金额:$ 38.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
This is a new program to train the next generation of scientists in the fields of hypertension and blood
pressure regulation. These conditions represent enormous health care problems. The new American Heart
Association and American College of Cardiology Guidelines now classify almost 50% of the adult
population as being hypertensive. Autonomic dysfunction, manifested by syncope, presyncope and
postural intolerance, becomes increasingly common with age and is terribly disabling. Despite the
commonality of these disorders, their precise etiology remains poorly defined. Moreover, they often
associated with and share underlying mechanisms with other cardiovascular and metabolic disorders. It is
therefore mandatory that we train and develop outstanding scientists to pursue these related areas of
investigation. We propose to ultimately include 4 post-doctoral fellows and 2 predoctoral graduate students
in Vanderbilt Hypertension and Blood Pressure Regulation (VHBPR) program. These trainees will be
involved in three related facets of research. One has to do with understanding mechanisms of hypertension
and end organ damage and the role inflammation and immune activation. Members of the VHBPR have led
the field in defining mechanisms of immune activation in hypertension and related fields and this has
evolved into a new understanding of the vascular, renal and cerebral dysfunction and damage that occurs
in this and associated cardiovascular illnesses. Trainees involved in these programs will become familiar
with an emerging area of immunology as it pertains to hypertension and cardiovascular diseases. The
second important area of investigation is conducted by our Vanderbilt Autonomic Dysfunction Center. This
center performs translational research involving laboratory, animal and clinical research. A third major area
of investigation relates to bioinformatics of hypertension and drug responses. These studies are greatly
facilitated by the BioVu database (the Vanderbilt DNA database) that contains DNA for >300,000 patients
and the Synthetic derivative (de-identified medical records linked to BioVu) and are facilitated by our
Division of Genetic Medicine and Center for Personalized Medicine. Our trainees will have the opportunity
to initiate studies on medication-resistant hypertension, as more than 15,000 BioVU subjects with
documented medication-resistant hypertension will have genome interrogation completed by 2018,
including a large number of African American subjects. In addition to these laboratory research
experiences, the VHBPR program includes seminars, didactic lectures and specialized course work
devoted to career development, leadership, responsible conduct of research and work life balance. In
addition to this core curriculum, trainees in specialized areas will participate in tailored coursework and
workshops related to their specific areas of investigation. The ultimate goal is to train successful scientists
that will successfully compete for future funding and who can pursue successful academic careers.
摘要
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David G Harrison其他文献
Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk
IL-1β 抑制对血压、高血压和残余炎症风险的影响
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:8.3
- 作者:
A. Rothman;Jean G Macfadyen;T. Thuren;A. Webb;David G Harrison;T. Guzik;P. Libby;R. Glynn;P. Ridker - 通讯作者:
P. Ridker
Posttranscriptional Regulation of Endothelial Nitric Oxide Synthase during Cell Growth Materials and Methods Cell Culture
细胞生长过程中内皮一氧化氮合酶的转录后调节 材料和方法 细胞培养
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Charles D. Searles;Yoichi Miwa;David G Harrison;S. Ramasamy;D. Searles - 通讯作者:
D. Searles
Isolevuglandins promote autoimmunity and hypertension in systemic lupus erythematosus
异黄兰素促进系统性红斑狼疮的自身免疫和高血压
- DOI:
10.1101/2020.02.10.20021741 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
David M. Patrick;N. Visitación;M. Ormseth;C. M. Stein;Sean S. Davies;Valery N. Yermalitsky;V. Amarnath;Leslie J. Crofford;Jonathan M Williams;S. Dikalov;A. Dikalova;Liang Xiao;Justin P. Van Beusecum;Mingfang Ao;A. Fogo;Kirabo Annet;David G Harrison - 通讯作者:
David G Harrison
88 - The Redox Sensitive Inactivation of Mitochondrial Sirt3, SOD2 Hyperacetylation and Complex I Superoxide Production in Endothelial Dysfunction and Hypertension
- DOI:
10.1016/j.freeradbiomed.2015.10.128 - 发表时间:
2015-10-01 - 期刊:
- 影响因子:
- 作者:
Anna E Dikalova;Hanna A Itani;Rafal R Nazarewicz;William G McMaster;Joshua P Fessel;Jorge L Gamboa;David G Harrison;Sergey Dikalov - 通讯作者:
Sergey Dikalov
REGIONAL VARIATION IN ARTERIAL RESPONSE TO NOREPINEPHRINE DURING FETAL (F) AND NEWBORN (N) LIFE
- DOI:
10.1203/00006450-198704010-00435 - 发表时间:
1987-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Kenneth T Nakamura;Beth M Alden;David G Harrison;Nancy J Rusch;Jean E Robillard - 通讯作者:
Jean E Robillard
David G Harrison的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David G Harrison', 18)}}的其他基金
Common Inflammation Pathways between Aging and Hypertension That Weaken Bone
衰老和高血压之间削弱骨骼的常见炎症途径
- 批准号:
10430633 - 财政年份:2022
- 资助金额:
$ 38.26万 - 项目类别:
Common Inflammation Pathways between Aging and Hypertension That Weaken Bone
衰老和高血压之间削弱骨骼的常见炎症途径
- 批准号:
10618349 - 财政年份:2022
- 资助金额:
$ 38.26万 - 项目类别:
Vanderbilt Hypertension and Blood Pressure Regulation Program
范德比尔特高血压和血压调节计划
- 批准号:
10385839 - 财政年份:2019
- 资助金额:
$ 38.26万 - 项目类别:
Mechanisms of T cell Activation in Hypertension
高血压中 T 细胞激活的机制
- 批准号:
9978625 - 财政年份:2016
- 资助金额:
$ 38.26万 - 项目类别:
The Role of Inflammation in Cardiovascular Disease
炎症在心血管疾病中的作用
- 批准号:
9978598 - 财政年份:2016
- 资助金额:
$ 38.26万 - 项目类别:
The Role of The T Cell In The Genesis of Hypertension
T 细胞在高血压发生中的作用
- 批准号:
9273740 - 财政年份:2015
- 资助金额:
$ 38.26万 - 项目类别:
相似海外基金
Vanderbilt Hypertension and Blood Pressure Regulation Program
范德比尔特高血压和血压调节计划
- 批准号:
10385839 - 财政年份:2019
- 资助金额:
$ 38.26万 - 项目类别:
Novel role of central AT2R in blood pressure regulation
中枢 AT2R 在血压调节中的新作用
- 批准号:
8805192 - 财政年份:2014
- 资助金额:
$ 38.26万 - 项目类别:
Novel role of central AT2R in blood pressure regulation
中枢 AT2R 在血压调节中的新作用
- 批准号:
9337482 - 财政年份:2014
- 资助金额:
$ 38.26万 - 项目类别:
Respiratory motor control and blood pressure regulation after spinal cord injury
脊髓损伤后的呼吸运动控制和血压调节
- 批准号:
8512772 - 财政年份:2011
- 资助金额:
$ 38.26万 - 项目类别:
Respiratory motor control and blood pressure regulation after spinal cord injury
脊髓损伤后的呼吸运动控制和血压调节
- 批准号:
8274900 - 财政年份:2011
- 资助金额:
$ 38.26万 - 项目类别:
Respiratory motor control and blood pressure regulation after spinal cord injury
脊髓损伤后的呼吸运动控制和血压调节
- 批准号:
8688329 - 财政年份:2011
- 资助金额:
$ 38.26万 - 项目类别:
Respiratory motor control and blood pressure regulation after spinal cord injury
脊髓损伤后的呼吸运动控制和血压调节
- 批准号:
8106571 - 财政年份:2011
- 资助金额:
$ 38.26万 - 项目类别:
Blood Pressure Regulation: Novel Roles for the Kidney
血压调节:肾脏的新作用
- 批准号:
8235821 - 财政年份:2009
- 资助金额:
$ 38.26万 - 项目类别:
Blood Pressure Regulation: Novel Roles for the Kidney
血压调节:肾脏的新作用
- 批准号:
8448082 - 财政年份:2009
- 资助金额:
$ 38.26万 - 项目类别:
Neurovascular Control and Blood Pressure Regulation in Humans
人类神经血管控制和血压调节
- 批准号:
8710314 - 财政年份:2007
- 资助金额:
$ 38.26万 - 项目类别: